Clinical Trials Logo

Clinical Trial Summary

The objective of study is to detect effect of remote ischemic preconditioning on serum lactate levels during and after cardiac surgery with cardiopulmonary bypass in addition to its effect on cardiac and renal clinical outcomes.


Clinical Trial Description

Remote ischemic preconditioning (RIPC) is a phenomenon where transient non-injurious ischemia/ reperfusion episodes applied to an organ away from the heart can protect the myocardium from ischemia/reperfusion injury. RIPC has been found to be an attractive strategy to reduce myocardial injury and improve outcome in patients undergoing cardiac surgery. The exact mechanisms of this protection are not yet known, although stimulation of prosurvival intracellular kinase responses and inhibition of inflammatory pathways each play a role. RIPC can be performed by noninvasive inflation and deflation of a standard blood pressure cuff or pneumatic tourniquet on the upper or lower limbs to induce brief ischemia and reperfusion, which is the mechanism by which injury in patients undergoing open cardiac surgery occurs. ANESTHETIC TECHNIQUE All patients will be preoperatively examined and investigated by complete blood count, coagulation profile, renal and kidney functions and electrolytes. Electrocardiography, chest x ray and echocardiography will be routinely done. Coronary angiography and carotid arterial duplex will be requested in patients prepared for coronary artery bypass graft (CABG). Patient will be premedicated by intramuscular injection of 10mg morphine in the morning of the operation. Before induction of anesthesia, a five-lead electrocardiography system will be applied to monitor heart rate, rhythm, and ST segments (leads II and V5). A pulse oximeter probe will be attached, and a peripheral venous cannula will be placed. For measurement of arterial pressure and blood sampling, a 20 G cannula will be inserted into either right or left radial artery under local anesthesia. General anesthesia will be induced by fentanyl (3-5 μg/kg), propofol titrated according to response, followed by atracurium (0.5 mg/kg). Trachea will be intubated, patients will be mechanically ventilated with oxygen in air so as to achieve normocarbia. This will be confirmed by radial arterial blood gas analysis. An esophageal temperature probe and a Foley catheter will also be placed. For drug infusion, a triple-lumen central venous catheter will be inserted via the right internal jugular vein. Anesthesia will be maintained by inhaled isoflurane, with additional fentanyl injected prior to skin incision as well as sternotomy and atracurium infusion for continued muscle relaxation. During extracorporeal circulation, patients will receive propofol infusion in addition to atracurium infusion. Before initiation of cardiopulmonary bypass (CPB), the patients will receive intravenously tranexamic acid (2 g) and heparin (300-500 units/kg body weight) to achieve an activated clotting time > 400 s. CPB was instituted via an ascending aortic cannula and a two-stage right atrial cannula. Before, during, and after CPB (pump blood flow: 2.4 l/min/m2), mean arterial pressure was adjusted to exceed 60 mmHg. Cardiac arrest will be induced with cold antegrade crystalloid cardioplegia (St Thomas solution) or warm intermittent antegrade blood cardioplegia. Lactate-enriched Ringer's solution will be added to the CPB circuit to maintain reservoir volume when needed, and packed red blood cells will be added when hemoglobin concentration decrease to less than 7 g/dl. After rewarming the patient to 37°C and separation from CPB, reversal of heparin by protamine sulfate, and sternal closure, the patients will be transferred to the intensive care unit. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03723993
Study type Interventional
Source Fayoum University
Contact
Status Withdrawn
Phase N/A
Start date January 15, 2018
Completion date December 15, 2018

See also
  Status Clinical Trial Phase
Withdrawn NCT00638040 - The Gene Expression Studies of the Role of Tumor Microenvironments in Tumor Progression N/A
Completed NCT00004493 - Phase II Pilot Randomized Study of Sodium Dichloroacetate in Patients With Congenital Lactic Acidemia Phase 2
Completed NCT00004490 - Phase III Randomized Study of Sodium Dichloroacetate in Children With Congenital Lactic Acidosis Phase 3
Withdrawn NCT03122678 - Thiamine Supplementation in Patients With Septic Shock Phase 1
Recruiting NCT03126890 - Investigation of the Correlation Between Plasma Concentration of Linezolid Antibiotic and Treatment Response and Adverse Reactions
Completed NCT01873859 - Safety of Continuing Metformin in Diabetic Patients With Normal Kidney Function Receiving Contrast Media N/A
Terminated NCT01354652 - Lactic Acidosis During Entecavir(ETV)Treatment Phase 4
Terminated NCT02974257 - Thiamine vs. Placebo to Increase Oxygen Consumption After Cardiac Arrest Phase 2
Active, not recruiting NCT05984186 - Wingate-type Exercise Test to Evaluate the Effect of High Velocity Therapy on Recovery Sensation and Blood Lactate Decline
Completed NCT01139463 - Study of Blood Lactate Levels in Patients Treated With Antipsychotics N/A
Completed NCT01901419 - Nitroglycerin Infusion During Cardiac Surgery N/A
Completed NCT00202228 - Lactate Metabolism Study in HIV Infected Persons Phase 4
Completed NCT04975906 - The Threshold of Serum Anion Gap as a Screening Tool for Organic Acidosis
Completed NCT00942123 - Study On the Role of Mitochondrial Dysfunction in the Pathogenesis of Metformin-associated Lactic Acidosis N/A
Withdrawn NCT01973504 - Phase 2c Dose Comparison Study of MP4OX in Trauma Phase 2
Completed NCT00015015 - Dichloroacetate Kinetics, Metabolism and Toxicology N/A
Completed NCT00004353 - Study of the Metabolism of Pyruvate and Related Problems in Patients With Lactic Acidemia N/A
Completed NCT03466528 - Alcohol: Thiamine and or Magnesium 1 Phase 2/Phase 3